Delcath Systems, Inc.

NASDAQ:DCTH

Medical - Devices

Healthcare
$19.70 -1.91%

-$0.23 today

Market cap
$685.32M
Beta
0.52
P/E (TTM)
751.4
EPS (TTM)
$0.02
52W Low $8.12High $14.48

Volume 0.59M

Average 0.42M

DCTH Effect of Forex Changes

Change in reported cash caused by exchange-rate movements on foreign-currency balances.

Delcath Systems, Inc.NASDAQ: DCTH

Effect of Forex Changes · Q1 FY2026 · quarter ended Mar 2026

Effect of forex changes turns negative

Q1 FY2026 effect of forex changes was -$46K, compared with $56K a year earlier. Trailing-twelve-month effect of forex changes was -$34K.

Context

  • Effect of forex changes amounted to 0.1% of revenue in FY2025, unchanged from a year earlier.
  • Effect of forex changes increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly effect of forex changes holds near -$46K or moves back toward the trailing-twelve-month quarterly average of -$8.5K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$46K-54.9% QoQ
Last fiscal yearDec 2025
$68K+312.5% YoY
LTMMar 2026
-$34K-585.7% YoY
Effect of Forex Changes past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-182.1%——
1 year+312.5%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Effect of Forex Changes history

USD · from the cash flow

Latest · FY2025
68K USD
Year-over-year change
+312.5%
4-year CAGR
-13.6%

Effect of Forex Changes vs competitors

How DCTH compares with its peers on the latest reported figures

  • DCTH's LTM Mar 2026 effect of forex changes of $34K is the 3rd largest of the 4 companies compared; the peer median is $37K.
  • Its year-over-year change of -585.7% is the lowest of 2, against a peer median of -66.1%.
  • Effect of forex changes amounts to 0.0% of revenue for DCTH, versus a peer median of 0.0%.
DCTH Competitors Peer median
Effect of Forex Changes for DCTH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TLSITriSalus Life Sciences, Inc.LTM Mar 2026$350K ——0.8%
NVCRNovoCure LimitedLTM Mar 2026$37K -66.1%—0.0%
DCTHDelcath Systems, Inc.LTM Mar 2026$34K -585.7%—0.0%
CATXPerspective Therapeutics, Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding DCTH) $37K-66.1%—0.0%

Competitors are the stored peer set for DCTH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(25.65M)(36.51M)(47.68M)(26.39M)2.7M
Depreciation & Amortization146K132K128K229K349K
Deferred Income Tax00000
Stock-Based Compensation7.83M7.94M8.15M9.77M24.23M
Change in Working Capital(5.76M)2.11M(906K)(15.52M)(3.07M)
Accounts Receivables13K(322K)125K(10.65M)(854K)
Inventory(557K)(587K)(1.32M)(3.61M)(3.32M)
Accounts Payables(1.14M)1.8M(199K)479K4.77M
Other Working Capital(4.08M)1.23M492K(1.74M)(3.66M)
Other Non-Cash Items831K1.37M9.05M13.23M(1.7M)
Operating Cash Flow(22.6M)(24.95M)(31.25M)(18.68M)22.52M
Capital Expenditures(143K)(209K)(58K)(559K)(1.55M)
Acquisitions (Net)00000
Purchases of Investments00(19.65M)(52.45M)(93.22M)
Sales of Investments00052.03M68.17M
Other Investing Activities00000
Investing Cash Flow(143K)(209K)(19.71M)(981K)(26.59M)
Debt Repayment14.44M(714K)(6.31M)(10.61M)0
Common Stock Issued3.92M10.86M23.08M7.02M21.05M
Common Stock Repurchased0000(6M)
Dividends Paid00000
Other Financing Activities2.46M035.01M43M0
Financing Cash Flow20.82M10.14M51.78M39.41M15.05M
Effect of Forex Changes122K(115K)56K(32K)68K
Net Change in Cash(1.8M)(15.13M)874K19.72M11.04M
Free Cash Flow(22.75M)(25.16M)(31.31M)(19.24M)20.97M

Delcath Systems, Inc.

NASDAQ:DCTH

Intrinsic Alpha fair value

Locked

Current Price

$19.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.